POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Tennessee: BlueCross will cover costs for COVID-19 booster

Christian Fernsby |
BlueCross BlueShield of Tennessee wants members to know that it will cover the administration cost for a COVID-19 booster for those who are moderately to severely immunocompromised, including those undergoing cancer treatment.

Article continues below

“We want to ensure those needing a COVID-19 booster understand their costs are covered,” said Dr. Andrea Willis, chief medical officer for BlueCross. “It’s our responsibility to support members seeking to protect themselves against COVID-19. Research has demonstrated the clear value of a booster to reduce risk, which ultimately will help communities facing the Delta variant surge.”

For commercial Blue Network S, P and L members, BlueCross will cover the cost of the fees associated with receiving the COVID-19 booster. If a BlueCross member is charged for their vaccine visit, they can call the Member Services number on the back of their Member ID card for help.

Medicare Advantage, BlueCare Tennessee and BlueCare Plus Tennessee members will also be able to get a booster without any out-of-pocket costs.

According to the CDC, COVID-19 vaccine boosters may be recommended for those who:

Are receiving active cancer treatment for tumors or cancers of the blood

Received an organ transplant and are taking medicine to suppress the immune system

Received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system

Have a moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)

Have an advanced or untreated HIV infection

Are underdoing active treatment with high-dose corticosteroids or other drugs that may suppress their immune response.

What to read next

Half million most vulnerable in UK to get third COVID-19 vaccine dose
EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty
Johnson & Johnson announces data to support boosting its single-shot COVID-19 vaccine